Nephrocare Health Services
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Nephrocare Health Services is navigating a period of moderate growth, primarily fueled by its international expansion efforts. Management has indicated that while revenue growth is slowing compared to historical performance, profitability is expected to improve as margins expand, despite recent pressures from a one-off provision. This aligns with Vista's forecast of a stable financial outlook, where revenue growth is projected to moderate but margins are anticipated to improve, supporting a fair valuation. The healthcare sector's current dynamics, characterized by stable pricing power and a shift towards corporate healthcare, further bolster Nephrocare's competitive position. However, the company must remain vigilant regarding margin pressures and regulatory risks that could impact profitability. Over the next 12-24 months, key opportunities include leveraging its international presence and capitalizing on the growing demand for organized tertiary care. Conversely, watchpoints include potential regulatory challenges and the impact of macroeconomic factors such as crude oil prices on operational costs
Why We Like This Stock
- International expansion is driving moderate revenue growth
- Management expects profitability to improve as margins expand
- The healthcare sector's shift towards corporate healthcare presents growth opportunities
Things To Watch Out For
- Revenue growth is slowing relative to historical performance
- Margins were recently impacted by a one-off provision
- Regulatory risks and macroeconomic factors could challenge profitability
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 566 | 756 | 999 | 1,217 | 1,463 |
| Profit Before Tax (Cr.) | 33 | 86 | 97 | 142 | 163 |
| PBT Margin | 5.8% | 11.4% | 971.0% | 11.7% | 11.2% |
| Net Profit (Cr.) | 31 | 69 | 62 | 106 | 123 |
| Earnings Per Share | 3.1 | 6.9 | 6.2 | 10.6 | 12.2 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| ICICI Securities | ► Hold | 660 | 22-May-2026 |
Company Overview
Show Company Profile
Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.